Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00948025 · ClinicalTrials.gov registry record · NA
A Comparative Post-marketing Study of Commercially Available Peripheral Nerve Gap Repair Options
A NA study, sponsored by Axogen Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT00948025: Clinical Trial NA study, sponsored by Axogen Corporation.
NCT00948025 is a NA study that was terminated before completion, run by Axogen Corporation. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00948025, a NA study, was terminated before completion, sponsored by Axogen Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
This study is a comparison of sensory recovery outcomes following the use of AVANCE Nerve Graft or hollow tube conduit for peripheral nerve gap repairs in the hand.
Primary Outcome
Mean change in static 2-Point Discrimination between baseline and 12 months
Interventions
- DEVICE Hollow tube nerve conduit, synthetic or biosynthetic
- OTHER Processed Human Nerve Tissue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2009-06 |
| Est. Completion | 2014-12 |
| Phase | NA |
Why NCT00948025 stopped before completion
NCT00948025 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Hollow tube nerve conduit, synthetic or biosynthetic is the first listed.
NCT00948025 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00948025 about?
NCT00948025 is a clinical study titled "A Comparative Post-marketing Study of Commercially Available Peripheral Nerve Gap Repair Options". This study is a comparison of sensory recovery outcomes following the use of AVANCE Nerve Graft or hollow tube conduit for peripheral nerve gap repairs in the hand.
What is the current status of trial NCT00948025?
This trial is currently terminated. It is a NA study. The enrollment target is 23 participants. The study started on 2009-06. Estimated completion is 2014-12.
What interventions are being tested in trial NCT00948025?
The interventions under investigation include: Hollow tube nerve conduit, synthetic or biosynthetic (DEVICE), Processed Human Nerve Tissue (OTHER).
Who is sponsoring clinical trial NCT00948025?
This trial is sponsored by Axogen Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00948025's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia